Showing results (1741-1750 of 1,820) with videos related to
Sort By:
Pageof 182
Nature Neuroscience|March 15, 2011
Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DATM Laura Cremona, Heinrich J G Matthies, Kelvin Pau, et al.Neurochemistry International|October 5, 2013
Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor functionChristine Saunders, Michael Siuta, Sabrina D Robertson, et al.Lasers in Surgery and Medicine|March 5, 2016
Comparative study of wound healing in rat skin following incision with a novel picosecond infrared laser (PIRL) and different surgical modalitiesHannes Petersen, Fatemeh Tavakoli, Sebastian Kruber, et al.Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|April 15, 2003
Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamicsWilliam T Abraham, Mary V Raynolds, David B Badesch, et al.Journal of Internal Medicine|March 13, 2019
The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based surveyB H Shaw, L E Stiles, K Bourne, et al.Journal of the American College of Cardiology|August 10, 2000
Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study GroupB D Lowes, M Higginbotham, L Petrovich, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|July 9, 2008
Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomasJingxin Qiu, Lingbao Ai, Cheppail Ramachandran, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II)Paulo M Hoff, Andreas Hochhaus, Bernhard C Pestalozzi, et al.Gynecologic Oncology|January 3, 2016
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapySusan M Domchek, Carol Aghajanian, Ronnie Shapira-Frommer, et al.Journal of the Autonomic Nervous System|January 23, 1999
Consensus statement on the diagnosis of multiple system atrophyS Gilman, P A Low, N Quinn, et al.Pageof 182